
Mukka Proteins IPO
- Issue price
- ₹28
- Listing price
- ₹40
- +42.86%
- Current price
- ₹26.49
- -5.39%
- Subscribed
- 136.99x
- Issue size
- ₹224 Cr
- Listed on
- 7 Mar 2024
IPO timeline
- Opens29 FebThu
- Closes4 MarMon
- Allotment5 MarTue
- Refunds6 MarWed
- Demat credit6 MarWed
- Listing7 MarThu
Issue details
- Price band
- ₹26 – ₹28 per share
- Issue size
- ₹224 Cr
- Fresh issue
- ₹224 Cr · 8 Cr shares
- Offer for sale
- None
- Issue type
- Fresh capital only
- Face value
- ₹1 per share
- Lot size
- 535 shares
- Minimum investment
- ₹14,980
- Listing on
- BSE, NSE
- Exchange code
- MUKKA · 544135
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 535 | ₹14,980 |
| Retail (Max) | 13 | 6,955 | ₹1,94,740 |
| S-HNI (Min) | 14 | 7,490 | ₹2,09,720 |
| B-HNI (Min) | 67 | 35,845 | ₹10,03,660 |
Reservation
- QIB
- 4,00,00,000 shares (50.00% of the Offer)
- NII
- 1,20,00,000 shares (15.00% of the Offer)
- Retail
- 2,80,00,000 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on Cameo Corporate Services- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 5 Mar 2024
- Refunds initiated
- 6 Mar 2024
- Shares credited to demat
- 6 Mar 2024
- Listing
- 7 Mar 2024
Grey market premium (GMP)
- Current GMP
- ₹30
- +107.00%
- Estimated listing price
- ₹58
- Issue price ₹28
- Highest
- ₹30
- 5 Mar
- Lowest
- ₹12
- 22 Feb
GMP by day (₹ per share)
Day-wise GMP table
| Date | GMP | Premium | Est. listing |
|---|---|---|---|
| 6 Mar 2024 | ₹30 | +107.00% | ₹58 |
| 5 Mar 2024 | ₹30 | +107.00% | ₹58 |
| 4 Mar 2024 | ₹25 | +89.00% | ₹53 |
| 2 Mar 2024 | ₹25 | +89.00% | ₹53 |
| 1 Mar 2024 | ₹25 | +89.00% | ₹53 |
| 29 Feb 2024 | ₹17 | +61.00% | ₹45 |
| 28 Feb 2024 | ₹17 | +61.00% | ₹45 |
| 27 Feb 2024 | ₹15 | +54.00% | ₹43 |
| 26 Feb 2024 | ₹15 | +54.00% | ₹43 |
| 23 Feb 2024 | ₹15 | +54.00% | ₹43 |
| 22 Feb 2024 | ₹12 | +43.00% | ₹40 |
| 21 Feb 2024 | ₹17 | +61.00% | ₹45 |
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB189.28x
- NII (HNI)250.39x
- Retail58.52x
Financials
- P/E (pre-issue)
- 12.96
- P/E (post-issue)
- 17.68
- EPS (₹)
- 2.20
- RoE
- 36.71%
- RoCE
- 17.62%
- RoNW
- 34.19%
- PAT Margin
- 4.04%
- Debt / Equity
- 1.64
- NAV (₹)
- 5.86
Pre-issue P/E uses the shares outstanding before the IPO; post-issue P/E includes the new shares. Calculated by Be IPO Ready at the issue price on profit for the FY ended 31 Mar 2023.
| Period ended | 30 Sep 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 641.18 | 575.16 | 392.30 | 353.93 |
| Total Income | 612.88 | 1,183.80 | 776.15 | 609.95 |
| Profit After Tax | 32.98 | 47.53 | 25.82 | 11.01 |
| NET Worth | 159.11 | 128.92 | 87.25 | 64.54 |
| Total Borrowing | 317.73 | 254.83 | 173.50 | 159.19 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Mukka Proteins This IPO | ₹224 Cr | 12.73 | 34.19% | 4.04% | 136.99x | +42.86% |
| Shree Tirupati Balajee Agro Trading Company Mainboard · listed 12 Sep 2024 | ₹169.65 Cr | 18.77 | 20.84% | 6.53% | 124.74x | +8.43% |
| Regaal Resources Mainboard · listed 20 Aug 2025 | ₹306 Cr | 21.98 | 20.25% | 5.19% | 159.88x | +38.24% |
| Nova AgriTech Mainboard · listed 31 Jan 2024 | ₹143.81 Cr | 18.27 | 32.08% | 9.73% | 113.21x | +34.15% |
| Amir Chand Jagdish Kumar (Exports) Mainboard · listed 2 Apr 2026 | ₹440 Cr | 22.56 | 11.87% | 4.76% | 3.41x | -5.66% |
| Crystal Crop Protection Mainboard · Upcoming | ₹455.49 Cr | 8.17 | 7.14% | 4.56% | — | — |
| Sanstar Mainboard · listed 26 Jul 2024 | ₹510.15 Cr | 25.93 | 30.92% | 6.17% | 82.99x | +14.74% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Mukka Proteins plans to use the money raised, as stated in the offer document.
- Funding working capital requirements of the Company₹120 Cr
- Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements; and₹10 Cr
- General Corporate Purpose₹55.81 Cr
About Mukka Proteins
Mukka Proteins Limited was incorporated in March 2003. It makes fish protein products, namely fish meal, fish oil and fish soluble paste. These are key ingredients for aqua feed for fish and shrimp, poultry feed for broilers and layers, and pet food. It also has an associate, Ento Proteins. It exports to countries such as Bahrain, Bangladesh, Chile, Indonesia, Malaysia, the Philippines, China, Saudi Arabia, South Korea, Oman, Taiwan and Vietnam. Its promoters are Kalandan Mohammed Haris, Kalandan Mohammad Arif and Kalandan Mohammed Althaf. The IPO was Rs 224 crore and was entirely fresh issue. Rs 120.00 crore was planned for working capital and Rs 10.00 crore for its associate Ento Proteins.
Strengths
- Total income rose from Rs 609.95 crore in FY2021 to Rs 1,183.80 crore in FY2023.
- Profit after tax rose from Rs 11.01 crore in FY2021 to Rs 47.53 crore in FY2023.
- The pre-issue P/E was 12.96 at the upper band of Rs 28, based on EPS of Rs 2.16.
- The whole Rs 224 crore issue was fresh capital, mostly for working capital.
- Profit after tax was Rs 32.98 crore in the six months to 30 September 2023.
Risks
- Total borrowing rose from Rs 159.19 crore on 31 March 2021 to Rs 317.73 crore on 30 September 2023.
- Margins are thin, and the source puts the PAT margin at 4.04%.
- Fish supply depends on catches, fishing bans and weather, which can swing volumes and prices, as income rose from Rs 776.15 crore in FY2022.
- Export sales add currency and trade risk, and the source puts debt to equity at 1.64.
- Promoters and the promoter group held 99.99% before the issue and 73.33% after it.
Promoters and shareholding
Kalandan Mohammed Haris, Kalandan Mohammad Arif and Kalandan Mohammed Althaf
- Promoter holding, pre-issue
- 99.99%
- Promoter holding, post-issue
- 73.33%
Anchor investors
| Investor | Shares allotted | Amount | % of anchor book |
|---|---|---|---|
| CRAFT EMERGING MARKET FUND PCC - ELITE CAPITAL FUND | 35,71,660 | ₹10 Cr | 14.88% |
| ELARA INDIA OPPORTUNITIES FUND | 35,71,660 | ₹10 Cr | 14.88% |
| EMINENCE GLOBAL FUND PCC - EUBILIA CAPITAL PARTNERS FUND I | 39,29,040 | ₹11 Cr | 16.37% |
| SAINT CAPITAL FUND | 35,73,800 | ₹10.01 Cr | 14.89% |
| NEOMILE GROWTH FUND - SERIES I | 57,81,745 | ₹16.19 Cr | 24.09% |
| ZINNIA GLOBAL FUND PCC - CELL DEWCAP FUND | 35,71,660 | ₹10 Cr | 14.88% |
Registrar, lead managers and documents
Lead manager
Documents
Mukka Proteins IPO: common questions
1.When does the Mukka Proteins IPO open and close?
The Mukka Proteins IPO opens on 29 Feb 2024 and closes on 4 Mar 2024.
2.What is the price band of the Mukka Proteins IPO?
The price band is ₹26 – ₹28 per share, with a lot size of 535 shares and a minimum investment of ₹14,980.
3.What is the size of the Mukka Proteins IPO?
The issue size is ₹224 Cr (Fresh capital only).
4.What is the GMP of the Mukka Proteins IPO?
The last reported grey market premium is ₹30 per share as of 06 Mar 2024, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Mukka Proteins IPO allotment?
The basis of allotment is expected on 5 Mar 2024. Allotment status can be checked with the registrar, Cameo Corporate Services Limited.
6.When will the Mukka Proteins IPO list?
The shares listed on 7 Mar 2024 on BSE, NSE.
7.Who is the lead manager of the Mukka Proteins IPO?
The book running lead manager is Fedex Securities Pvt. Ltd, and the registrar is Cameo Corporate Services Limited.
8.What will the money raised in the Mukka Proteins IPO be used for?
As stated in the offer document, the proceeds are for: Funding working capital requirements of the Company; Investment in our Associate, viz. Ento Proteins Private Limited, for funding its working capital requirements; and; General Corporate Purpose.
9.How can my company launch an IPO like Mukka Proteins?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393